Compass Therapeutics Inc.
CMPX | NASDAQ
$1.82
-$0.08 (-4.21%)
At close: Sep 21, 2026, 4:00 PM ET
$1.07
-$0.75 (-41.21%)
Pre-market:
Sep 22, 2026, 8:44 AM ET
Market Data
Market Cap $327.76M
Enterprise Value $157.51M
Beta 0.85
Average Volume 7.58M
Shares Outstanding (Diluted) 186.8M
Shares Change YoY 35.08%
Institutional Ownership 92.94%
Exchange NASDAQ
ISIN US20454B1044
Price Performance
Price Change 1M -24.5%
Price Change 3M -11.7%
Price Change 6M -66.8%
Price Change YTD -64.8%
Price Change 1Y -47.9%
Price Change 3Y -7.1%
Price Change 5Y -48.0%
1M CAGR (ann.) -15.3%
1Y CAGR (ann.) -50.5%
5Y CAGR (ann.) -12.3%
All-Time CAGR -24.6%
Valuation
PE Ratio -4.44
Forward PE N/A
PEG Ratio -0.50
Forward PEG -0.42
PS Ratio N/A
Forward PS 14.10
PB Ratio 1.97
P/FCF Ratio -5.95
P/Adj. FCF Ratio -4.82
P/OCF Ratio -6.28
EV/Sales N/A
EV/EBIT -2.14
EV/EBITDA -2.17
EV/FCF -2.86
Earnings Yield -22.5%
FCF Yield -16.8%
Adj. FCF Yield -20.8%
Financial Health
Net Cash $170.25M
Total Debt $9.63M
Cash & Short-Term Investments $179.88M
Total Assets $190.17M
Current Ratio 11.22
Quick Ratio 11.22
Debt / Equity Ratio 0.06
Debt / EBITDA -0.13
Debt / FCF -0.18
OCF / Debt -5.69
Interest Coverage 0.00
Altman Z-Score 4.42
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -23.5%
Returns
Return on Assets -38.6%
Return on Equity -38.7%
Return on Invested Capital -46.1%
Return on Capital Employed -46.6%
Return on Tangible Assets -38.6%
Historical Growth (CAGR)
Revenue CAGR 3Y -150.0%
Revenue CAGR 5Y 0.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -6.2%
EPS CAGR 5Y 1.9%
EPS CAGR 10Y N/A
FCF CAGR 3Y -12.7%
FCF CAGR 5Y -16.0%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 16
EPS Growth Next 3Y 52.9%
Revenue Growth Next 3Y N/A
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$0.12
EPS Growth Est (next Q) 50.0%
Revenue Est (next Q) $229.25K
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $6
Price Target Upside 229.7%
Cash Flow
Operating Cash Flow $-54.79M
Free Cash Flow $-55.05M
Adj. Free Cash Flow $-68.01M
FCF Per Share -$0.29
OCF Per Share -$0.29
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-738K
Operating Income $-81.09M
EBITDA $-72.67M
Net Income $-73.45M
EPS (Diluted) -$0.41
Revenue / Employee N/A
Profit / Employee $-1.88M
Employees 39
Add to Watchlist
Select watchlists to add or remove CMPX